PHKA2
Basic information
Region (hg38): X:18892298-18984114
Previous symbols: [ "PHK", "PYK" ]
Links
Phenotypes
GenCC
Source:
- glycogen storage disease IXa1 (Strong), mode of inheritance: XL
- glycogen storage disease IXa1 (Definitive), mode of inheritance: XL
- glycogen storage disease IXa1 (Strong), mode of inheritance: XL
- glycogen storage disease due to liver phosphorylase kinase deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glycogen storage disease, type IXa1 | XL | Biochemical; Gastrointestinal | The condition can include manifestations such as hypoglycemia, ketosis, and growth retardation, and recommendations for care include laboratory-based monitoring (eg, including liver function tests, glucose, and ketones), radiological monitoring (abdominal imaging), and nutritional recommendations and avoidance of certain medications in order to help improve metabolic to control and prevent the primary complications; Specific care during pregnancy has been recommended | Biochemical; Gastrointestinal; Musculoskeletal; Neurologic | 5306139; 4518931; 280544; 2303074; 7711737; 7847371; 8733134; 9600238; 9835437; 9870210; 10330341; 11286390; 12809646; 12862311; 16354226; 17581768; 17689125; 19856867; 21131218; 21646031; 21634085; 21844581; 21857251; 21911307; 24055370; 25266922; 30659246; 33317799 |
ClinVar
This is a list of variants' phenotypes submitted to
- Glycogen_storage_disease_IXa1 (350 variants)
- not_provided (165 variants)
- Inborn_genetic_diseases (109 variants)
- not_specified (78 variants)
- PHKA2-related_disorder (35 variants)
- Glycogen_storage_disease_IXa2 (8 variants)
- Glycogen_phosphorylase_kinase_deficiency (5 variants)
- Glycogen_storage_disease_IXd (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
- Increased_hepatic_glycogen_content (1 variants)
- Genetic_developmental_and_epileptic_encephalopathy (1 variants)
- Aland_island_eye_disease (1 variants)
- Abnormality_of_neuronal_migration (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHKA2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000292.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 68 | 11 | 82 | |||
missense | 10 | 28 | 205 | 52 | 299 | |
nonsense | 26 | 31 | ||||
start loss | 1 | 1 | 2 | |||
frameshift | 21 | 29 | ||||
splice donor/acceptor (+/-2bp) | 21 | 28 | ||||
Total | 65 | 62 | 209 | 120 | 15 |
Highest pathogenic variant AF is 0.0000579114
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHKA2 | protein_coding | protein_coding | ENST00000379942 | 33 | 92299 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.384 | 0.616 | 125736 | 3 | 9 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 404 | 521 | 0.775 | 0.0000446 | 8091 |
Missense in Polyphen | 91 | 175.63 | 0.51815 | 2743 | ||
Synonymous | -2.04 | 257 | 219 | 1.18 | 0.0000207 | 2414 |
Loss of Function | 5.01 | 11 | 48.8 | 0.225 | 0.00000354 | 802 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000760 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000144 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000110 | 0.0000791 |
Middle Eastern | 0.000144 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin.;
- Disease
- DISEASE: Glycogen storage disease 9A (GSD9A) [MIM:306000]: A metabolic disorder resulting in a mild liver glycogenosis with clinical symptoms that include hepatomegaly, growth retardation, muscle weakness, elevation of glutamate-pyruvate transaminase and glutamate-oxaloacetate transaminase, hypercholesterolemia, hypertriglyceridemia, and fasting hyperketosis. Two subtypes are known: type 1 or classic type with no phosphorylase kinase activity in liver or erythrocytes, and type 2 or variant type with no phosphorylase kinase activity in liver, but normal activity in erythrocytes. Unlike other glycogenosis diseases, glycogen storage disease type 9A is generally a benign condition. Patients improve with age and are often asymptomatic as adults. Accurate diagnosis is therefore also of prognostic interest. {ECO:0000269|PubMed:10330341, ECO:0000269|PubMed:17689125, ECO:0000269|PubMed:7549948, ECO:0000269|PubMed:7847371, ECO:0000269|PubMed:8733133, ECO:0000269|PubMed:8733134, ECO:0000269|PubMed:9600238}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glucagon signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Type II diabetes mellitus;Glycogen Metabolism;Metabolism of carbohydrates;Metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism
(Consensus)
Recessive Scores
- pRec
- 0.392
Intolerance Scores
- loftool
- 0.0519
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 19.05
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- Y
- hipred_score
- 0.589
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.625
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phka2
- Phenotype
Gene ontology
- Biological process
- carbohydrate metabolic process;glycogen metabolic process;generation of precursor metabolites and energy;cellular protein modification process;protein phosphorylation
- Cellular component
- cytosol;plasma membrane;phosphorylase kinase complex
- Molecular function
- phosphorylase kinase activity;protein binding;calmodulin binding